Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce that it is presenting a scientific poster demonstrating that its lead compound, ECO-4601, is active in vivo against breast and prostate cancer. This poster is presented today in Philadelphia, Pennsylvania at the oncology conference sponsored by the American Association for Cancer Research (AACR), jointly with the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC). The data has originally been disclosed by way of a press release dated May 17, 2005.
